Creative Biolabs-Immuno-oncology

Anti-DVL2 (clone 7JA3) SynExpress E1-G-GR-E Modified CD8+ T cells (CAT#: ITS-1224-CR2405)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DVL2 (clone 7JA3). We employs the Lentivirus (EF1α-GFP-GR-EcoRI) vector components and the SynExpress system of the Exons Inversion/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DVL2
Clone
7JA3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.91
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.